Return to program book search
Current Pathogenic and Therapeutic Concepts in Inflammatory Skin Diseases
Monday, March 24
3:30 PM - 5:30 PM
Emma Guttman, MD, PhD, FAAD
- Kevin D. Cooper, MD, FAAD
- James G. Krueger, MD, PhD, FAAD
Following this course, the attendee should be able to:
- Recognize evolving pathogenic mechanisms underlying psoriasis, atopic and contact dermatitis.
- Determine the immune and barrier differences and similarities between the most common inflammatory skin diseases (psoriasis, atopic and contact dermatitis).
- Recognize the immune basis for existing and emerging therapeutics in psoriasis, atopic dermatitis and contact dermatitis.
The session will discuss pathogenic concepts in inflammatory skin diseases, including psoriasis, atopic and contact dermatitis and the immune basis for exciting therapeutic developments for these diseases. Differences and similarities in clinical, immune and barrier abnormalities between these diseases will be outlined, including therapeutic relevance. We will also discuss the potential link between barrier and immune abnormalities. The discussion will be framed around the idea that distinct inflammatory skin diseases may have driver cytokines that mediate disease pathology. At the end of the forum the audience will recognize unique features of these diseases as compared to general skin inflammation characteristics.
|Monday, March 24|
|3:30 PM||Introduction / Dr. Guttman|
|3:35 PM||Current concepts in contact dermatitis / Dr. Cooper|
|4:10 PM||Psoriasis: Pathogenesis and targeted therapeutics / Dr. Krueger|
|4:45 PM||Evolving concepts and therapeutics in atopic dermatitis / Dr. Guttman|
|5:20 PM||Q & A session / All faculty|